Don’t Delay Lung Cancer Immunotherapy Treatment Over Fear of COVID-19

Updated March 30th, 2022

Don’t Delay Lung Cancer Immunotherapy Treatment Over Fear of COVID-19

NOW
PLAYING
A Stranger Saves a 37-Year-Old Mom's Life By Warning Her About a Suspicious-Looking Mole on Her Arm
NOW
PLAYING
Doctors Said He'd Never Run Again with Only One Lung—Survivor Greg Gerardy, 50, Proved Them Wrong After 5th Marathon
NOW
PLAYING
Brave Lung Cancer Survivor & Matriarch of ‘Alaskan Bush People’ Family Ami Brown’s Request to Dismiss Federal $500K Lawsuit Against Husband’s Estate is Denied
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
She Gave Her Boyfriend a Chance to Bounce After Her Cancer Diagnosis; He Chose to Stay Put and Blew Her Mind
NOW
PLAYING
How The FDA's Approval of a New Immunotherapy Improves The Treatment of Eye Cancer

Later Stage Treatment: The Importance of Biomarker Testing

SEE MORE   

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.

Later Stage Treatment: The Importance of Biomarker Testing

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.